av/marksans-pharma--big.svg

COM:MARKSANSPHARMA

Marksans Pharma

  • Stock

Last Close

288.60

12/11 09:59

Market Cap

87.17B

Beta: -

Volume Today

6.81M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
719.08M
-
1.09B
52.13%
1.07B
2.33%
155.29M
85.47%
497.98M
220.67%
1.04B
109.46%
1.57B
50.68%
3.02B
92.25%
2.48B
18.09%
3.38B
36.42%
3.14B
7.09%
depreciation and amortization
156.91M
-
161.34M
2.82%
281.27M
74.33%
300.93M
6.99%
268.38M
10.82%
228.04M
15.03%
266.62M
16.92%
361.51M
35.59%
447.76M
23.86%
518.53M
15.81%
742.70M
43.23%
deferred income tax
stock based compensation
change in working capital
-260.10M
-
208.52M
180.17%
-841.64M
503.62%
-241.00M
71.37%
-273.96M
13.68%
-817.92M
198.56%
357.34M
143.69%
-1.50B
519.85%
-1.11B
26.21%
-1.11B
0.69%
-1.26B
13.21%
accounts receivables
3.09M
-
-667.55M
21,728.79%
-367.44M
44.96%
-1.04B
182.86%
-275.18M
73.52%
-371.67M
35.06%
inventory
-248.97M
-
-275.18M
10.53%
-376.85M
36.95%
-222.95M
40.84%
-280.37M
25.75%
-751.22M
167.94%
514.02M
168.42%
-1.62B
416.09%
-178.49M
89.01%
-448.50M
151.27%
-1.13B
151.22%
accounts payables
90.37M
-
665.73M
636.70%
417.84M
37.24%
184.90M
55.75%
224.23M
21.27%
526.89M
134.98%
other working capital
-11.13M
-
483.70M
4,443.99%
-464.79M
196.09%
-18.04M
96.12%
6.41M
135.55%
-160.15M
2,596.89%
-154.87M
3.30%
74.08M
147.83%
-74.09M
200.01%
-615.20M
730.34%
-290.41M
52.79%
other non cash items
32.50M
-
81.31M
150.14%
-200.13M
346.14%
-126.80M
36.64%
96.80M
176.34%
-179.23M
285.17%
-96.23M
46.31%
-95.47M
0.80%
-823.28M
762.37%
-406.29M
50.65%
2.40B
690.75%
net cash provided by operating activities
648.39M
-
1.55B
138.30%
308.00M
80.07%
88.42M
71.29%
589.20M
566.34%
273.95M
53.50%
2.10B
666.36%
1.79B
14.86%
992.57M
44.47%
2.37B
139.19%
2.56B
7.87%
investments in property plant and equipment
-364.66M
-
-1.32B
261.64%
-277.49M
78.96%
-389.35M
40.31%
-131.47M
66.23%
-596.27M
353.55%
-464.24M
22.14%
-463.30M
0.20%
-536.31M
15.76%
-2.09B
289.40%
acquisitions net
-52.08M
-
2.82M
-
5.20M
84.38%
340K
93.46%
-266.10M
78,364.71%
8.54M
103.21%
purchases of investments
-1.50M
-
-1.90B
126,410.67%
-370.01M
80.50%
sales maturities of investments
951.63K
-
-340K
-
2.16B
636,500.00%
732.78M
66.13%
other investing activites
7.20M
-
32.76M
355.05%
88.63M
170.52%
69.05M
22.09%
1.56M
97.74%
-4.28M
374.67%
-1.85M
56.71%
10.08M
643.89%
47.94M
375.54%
-2.06B
4,388.30%
net cash used for investing activites
-44.88M
-
-331.89M
639.51%
-1.23B
270.64%
-208.44M
83.06%
-387.79M
86.05%
-134.80M
65.24%
-595.30M
341.63%
-448.96M
24.58%
-416.86M
7.15%
-2.59B
521.82%
-1.72B
33.76%
debt repayment
-84.65M
-
-998.67M
1,079.82%
-334.97M
66.46%
-66.78M
-
-703.05M
952.84%
-1.03M
99.85%
-225.52M
21,898.75%
-2.30B
917.84%
-124.97M
94.56%
common stock issued
1.31B
-
703.05M
-
911.55M
-
2.75B
201.36%
common stock repurchased
-10M
-
-15M
-
-10M
33.33%
-50M
-
-225.52M
-
-451.66M
100.27%
dividends paid
-104.24M
-
-69.72M
33.12%
-179.61M
157.63%
-145.30M
19.10%
-24.63M
83.05%
-44.44M
80.42%
-295.03M
563.87%
-40.93M
86.13%
-105.83M
158.55%
-101.71M
3.89%
-226.58M
122.77%
other financing activites
-103.96M
-
-64.10M
38.34%
-62.94M
1.80%
178.92M
384.25%
-19.63M
110.97%
-96.55M
391.84%
-556.45M
476.31%
-110.90M
80.07%
440.43M
497.13%
2.08B
372.27%
net cash used provided by financing activities
-292.84M
-
169.94M
158.03%
-577.53M
439.83%
18.62M
103.22%
-54.26M
391.43%
-207.77M
282.90%
-901.48M
333.88%
-152.86M
83.04%
795.11M
620.16%
1.98B
148.81%
-635.55M
132.13%
effect of forex changes on cash
6.06M
-
-1.03M
117.02%
-1.43B
138,303.25%
20K
100.00%
net change in cash
310.67M
-
1.38B
345.22%
-1.50B
208.42%
-101.39M
93.24%
147.15M
245.13%
-68.62M
146.63%
602.66M
978.29%
1.19B
96.73%
1.37B
15.62%
1.76B
28.41%
2.91B
65.15%
cash at beginning of period
158.80M
-
469.47M
195.64%
1.85B
294.63%
353.01M
80.95%
251.62M
28.72%
397.17M
57.84%
328.55M
17.28%
937.27M
185.28%
2.12B
126.38%
2.06B
2.72%
3.83B
85.49%
cash at end of period
469.47M
-
1.85B
294.63%
353.01M
80.95%
251.62M
28.72%
398.77M
58.48%
328.55M
17.61%
931.21M
183.43%
2.12B
127.97%
3.49B
64.53%
3.82B
9.50%
6.74B
76.13%
operating cash flow
648.39M
-
1.55B
138.30%
308.00M
80.07%
88.42M
71.29%
589.20M
566.34%
273.95M
53.50%
2.10B
666.36%
1.79B
14.86%
992.57M
44.47%
2.37B
139.19%
2.56B
7.87%
capital expenditure
-364.66M
-
-1.32B
261.64%
-277.49M
78.96%
-389.35M
40.31%
-131.47M
66.23%
-596.27M
353.55%
-464.24M
22.14%
-463.30M
0.20%
-536.31M
15.76%
-2.09B
289.40%
free cash flow
648.39M
-
1.18B
82.06%
-1.01B
185.62%
-189.06M
81.29%
199.85M
205.71%
142.49M
28.70%
1.50B
954.97%
1.32B
11.97%
529.27M
60.00%
1.84B
247.23%
472.64M
74.28%

All numbers in (except ratios and percentages)